Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06353152 · UNKNOWN
Trial details
- NCT number
- NCT06353152
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-11-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.